Complement activation is involved in the structural deterioration of bovine pericardial bioprosthetic heart valves

ASAIO Journal

Volumn 42, Issue 5, 1996, Pages

  Moczar, M ^a   Lecerf, L ^a   Ginat, M ^a   Loisance, D ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN-ANTIBODY REACTIONS; BIOASSAY; CELLS; COLLAGEN; DETERIORATION; ENZYMES;

BOVINE PERICARDIAL VALVES; CHEMOTAXIS; COMPLEMENT ACTIVATION; FIBRIN; HUMAN PLASMAS; NONCALCIFIC DETERIORATION;

HEART VALVE PROSTHESES;

COLLAGEN; COLLAGEN FIBER;

ANIMAL TISSUE; ARTICLE; BIOPROSTHESIS; CATTLE; COMPLEMENT ACTIVATION; HEART VALVE PROSTHESIS; NONHUMAN; PERICARDIUM; PROSTHESIS FAILURE;

EID: 0030250664     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002480-199609000-00015     Document Type: Article

References (18)

1. Masters RG, Pipe AC, Bed hard JP, et al: Long term clinical results with lonescu-Shiley pericardial xenografts. J Thorac Cardiovasc Surg 101: 81-89, 1991.
2. Schoen F, Fernandez J, Gonzalez-Lanvin L, Cernaianu A: Causes of failure and pathologic findings in surgically removed lonescu-Shiley standard bovine pericardial heart valve bioprostheses: emphasis on progressive structural deterioration. Circulation 76: 618-627, 1987.
3. Trowbridge EA, Lawford PV, Crofts CE, Roberts KM: Pericardial grafts: why do these valves fail? J Thorac Cardiovasc Surg 95: 577-585, 1988.
4. Léandri J, Bertrand P, Mazzucotelli JP, Loisance DY: Mode of failure of the Mitroflow pericardial valve. J Heart Valve Dis 1: 226-231, 1992.
5. Vetter HO, Krupa W, Nerlich A, et al: New morphologic aspects of explanted Hancock extracorporeal pericardial bioprostheses. J Heart Valve Dis 3: 335-343, 1994.
6. Walley MV, Keon W: Failure of Hancock pericardial bioprostheses. J Heart Valve Dis 3: 585, 1994.
7. Mazzucotelli JP, Bertrand P, Loisance DY: The Mitroflow pericardial valve: clinical performance to 10 years. J Heart Valve Dis 4: 407-413, 1995.
8. Moczar M, Mazzucotelli JP, Bertrand P, Ginat M, Léandri J, Loisance DY: Deterioration of bioprosthetic heart valves. ASAIO J 40: M697-M701, 1994.
9. Ciernievski C, Plow EF, Eddington TS: An immunochemical homology between the Aa and DE complex-dependent site of the γ chain of the fibrinogen. J Biol Chem 252: 8917-8923, 1977.
10. Abbas AK, Lichtman AH, Pober JS: The complement system, in Abbas AK, Lichtman AH, Pober JS (eds), Cellular and Molecular Immunology, Philadelphia, WB Saunders 1994, pp. 295-315.
11. Walport M. Complement, in Roitt I, Brostoff J, Male D, (eds), Immunology, London, Gower, 1989, pp. 13.1-13.6.
12. Dahm M, Lyman WD, Schwell AB, Factor SM, Frater RWM: Immunogenicity of glutaraldehyde tanned bovine pericardium. J Thorac Cardiovasc Surg 99: 1082-90, 1990.
13. Gong G, Seifter E, Lyman WD, Factor SM, Blau S, Frater WM: Bioprosthetic cardiac valve degeneration: role of inflammatory and immune reactions. J Heart Valve Dis 2: 684-693, 1993.
14. Levy RJ, Schoen FJ, Howard SL: Mechanism of calcification of porcine bioprosthetic aortic valve cusps: role of T lymphocytes. Am J Cardiol 52: 629-631, 1983.
15. Sherman LA, Lee J: Specific binding of soluble fibrin to macrophages. J Exp Med 154: 76-85, 1977.
16. Hughes H, Tipton LS, Feuchuk D, Prabhakar G, Aboul-Enen HY, Duran CMG: Glutaraldehyde γ carboxyglutamic acid and calcium in explanted bioprosthetic heart valves. J Heart Valve Dis 3: 111-116, 1994.
17. Lee MJ, Boughner DR: Tissue mechanics of canine pericardium in different test environment: evidence for time dependent accommodation, absence of plasticity and new roles for collagen and elastin. Circ Res 49: 533-544, 1981.
18. Scott M, Vesely I: Aortic valve cusp microstructure: the role of elastin. Ann Thorac Surg 60: S391-S394, 1995.